These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 26758977)

  • 21. Site-specific blockade of RAGE-Vd prevents amyloid-beta oligomer neurotoxicity.
    Sturchler E; Galichet A; Weibel M; Leclerc E; Heizmann CW
    J Neurosci; 2008 May; 28(20):5149-58. PubMed ID: 18480271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Magnesium Reduces Blood-Brain Barrier Permeability and Regulates Amyloid-β Transcytosis.
    Zhu D; Su Y; Fu B; Xu H
    Mol Neurobiol; 2018 Sep; 55(9):7118-7131. PubMed ID: 29383689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Linguizhugan decoction on neuroinflammation and expression disorder of the amyloid β‑related transporters RAGE and LRP‑1 in a rat model of Alzheimer's disease.
    Hu Q; Yu B; Chen Q; Wang Y; Ling Y; Sun S; Shi Y; Zhou C
    Mol Med Rep; 2018 Jan; 17(1):827-834. PubMed ID: 29115637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RAGE mediated intracellular Aβ uptake contributes to the breakdown of tight junction in retinal pigment epithelium.
    Park SW; Kim JH; Park SM; Moon M; Lee KH; Park KH; Park WJ; Kim JH
    Oncotarget; 2015 Nov; 6(34):35263-73. PubMed ID: 26431165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival.
    Kang R; Tang D; Schapiro NE; Livesey KM; Farkas A; Loughran P; Bierhaus A; Lotze MT; Zeh HJ
    Cell Death Differ; 2010 Apr; 17(4):666-76. PubMed ID: 19834494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Receptor for advanced glycation end products mediates sepsis-triggered amyloid-β accumulation, Tau phosphorylation, and cognitive impairment.
    Gasparotto J; Girardi CS; Somensi N; Ribeiro CT; Moreira JCF; Michels M; Sonai B; Rocha M; Steckert AV; Barichello T; Quevedo J; Dal-Pizzol F; Gelain DP
    J Biol Chem; 2018 Jan; 293(1):226-244. PubMed ID: 29127203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of p38/MAPKs in Alzheimer's disease: implications for amyloid beta toxicity targeted therapy.
    Kheiri G; Dolatshahi M; Rahmani F; Rezaei N
    Rev Neurosci; 2018 Dec; 30(1):9-30. PubMed ID: 29804103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ectodomain shedding of the receptor for advanced glycation end products: a novel therapeutic target for Alzheimer's disease.
    Zhang L; Postina R; Wang Y
    Cell Mol Life Sci; 2009 Dec; 66(24):3923-35. PubMed ID: 19672558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 6-Phenoxy-2-phenylbenzoxazoles, novel inhibitors of receptor for advanced glycation end products (RAGE).
    Choi K; Lim KS; Shin J; Kim SH; Suh YG; Hong HS; Kim H; Ha HJ; Kim YH; Lee J; Lee J
    Bioorg Med Chem; 2015 Aug; 23(15):4919-4935. PubMed ID: 26051601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two β-strands of RAGE participate in the recognition and transport of amyloid-β peptide across the blood brain barrier.
    Kim SJ; Ahn JW; Kim H; Ha HJ; Lee SW; Kim HK; Lee S; Hong HS; Kim YH; Choi CY
    Biochem Biophys Res Commun; 2013 Sep; 439(2):252-7. PubMed ID: 23973487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism.
    Lue LF; Walker DG; Brachova L; Beach TG; Rogers J; Schmidt AM; Stern DM; Yan SD
    Exp Neurol; 2001 Sep; 171(1):29-45. PubMed ID: 11520119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of RAGE in Alzheimer's Disease.
    Cai Z; Liu N; Wang C; Qin B; Zhou Y; Xiao M; Chang L; Yan LJ; Zhao B
    Cell Mol Neurobiol; 2016 May; 36(4):483-95. PubMed ID: 26175217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Every Cloud Has a Silver Lining: Proneurogenic Effects of Aβ Oligomers and HMGB-1 via Activation of the RAGE-NF-κB Axis.
    Bortolotto V; Grilli M
    CNS Neurol Disord Drug Targets; 2017; 16(10):1066-1079. PubMed ID: 27488419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycation exacerbates the neuronal toxicity of β-amyloid.
    Li XH; Du LL; Cheng XS; Jiang X; Zhang Y; Lv BL; Liu R; Wang JZ; Zhou XW
    Cell Death Dis; 2013 Jun; 4(6):e673. PubMed ID: 23764854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RAGE Isoforms, its Ligands and their Role in Pathophysiology of Alzheimer's Disease.
    Chellappa RC; Palanisamy R; Swaminathan K
    Curr Alzheimer Res; 2020; 17(14):1262-1279. PubMed ID: 33602095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic cerebral hypoperfusion-induced impairment of Aβ clearance requires HB-EGF-dependent sequential activation of HIF1α and MMP9.
    Ashok A; Rai NK; Raza W; Pandey R; Bandyopadhyay S
    Neurobiol Dis; 2016 Nov; 95():179-93. PubMed ID: 27431094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Docking and Molecular Dynamics-Based Identification of Interaction between Various Beta-Amyloid Isoforms and RAGE Receptor.
    Tolstova AP; Adzhubei AA; Mitkevich VA; Petrushanko IY; Makarov AA
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RAGE regulates BACE1 and Abeta generation via NFAT1 activation in Alzheimer's disease animal model.
    Cho HJ; Son SM; Jin SM; Hong HS; Shin DH; Kim SJ; Huh K; Mook-Jung I
    FASEB J; 2009 Aug; 23(8):2639-49. PubMed ID: 19332646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. mTORC2 (Rictor) in Alzheimer's Disease and Reversal of Amyloid-β Expression-Induced Insulin Resistance and Toxicity in Rat Primary Cortical Neurons.
    Lee HK; Kwon B; Lemere CA; de la Monte S; Itamura K; Ha AY; Querfurth HW
    J Alzheimers Dis; 2017; 56(3):1015-1036. PubMed ID: 28035937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. G82S polymorphism of receptor for advanced glycation end products gene and serum soluble RAGE levels in mild cognitive impairment and dementia of Alzheimer's type patients in Turkish population.
    Ataç ZS; Alaylıoğlu M; Dursun E; Gezen-Ak D; Yılmazer S; Gürvit H
    J Clin Neurosci; 2019 Jan; 59():197-201. PubMed ID: 30389362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.